Saturday, March 18, 2017 8:19:56 AM
http://otcshortreport.com/?index=CNBX&action=view
1.2Mil of the 14Mil share FLOAT is SHORT
http://shortsqueeze.com/?symbol=Cnbx&submit=Short+Quote%E2%84%A2
THE RISK FACTORS IN THE 10K WERE ALREADY SATISFIED. IF YOU READ THE MOST RECENT 10Q, THEY ALREADY RAISED ANOTHER $500K ON JANUARY 7TH AND ONLY NEEDEE 1 MILLION FOR THE ENTIRE YEAR <2017>
The Company MOST likely SOLD another 500k shares since January 7th, netting them another $1.5 million , which will remove any Going Concern reflected in the 2016 10K which was before the stock ran and pretty much OBSOLETE at this point.
SHORT SELLERS WANT TO POINT TO OBSOLETE INFORMATION TO CONVINCE OR SCARE PEOPLE INTO SELLING THERE SHARES. BIG NEWS COMING, ON THE DIAGNOSTIC TESTS AND PHASE 3 TRIAL
CNBX PHASE 3 TRIAL Official Cannabics Capsules as Treatment to Improve Cancer Related Cachexia and Anorexia Syndrome in Advanced Cancer
https://clinicaltrials.gov/ct2/show/NCT02359123
CNBX READ THIS. SEE THE LINK BELOW. IMPRESSIVE! Cannabics Pharmaceuticals Announces Initial Commercialization of Cannabinoids-based Personalized Diagnostics for Cancer Patients
http://www.bizjournals.com/prnewswire/press_releases/2017/02/06/LN05175
CNBX Commercialization will commence in March 2017, when 10 first patients' liquid biopsies will be tested using this technology. The company plans to make this service available to cancer patients in Canada, Europe and the USA, under local medical cannabis regulations in each country and state, by the end of the year. Itamar Borochov, CEO of Cannabics Pharmaceuticals, says "We are the first company in the world to offer cancer patients personalized cannabinoid anti-tumor diagnostics. We are excited to be pioneers in the nexus of cannabis and personalized cancer treatments".
http://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-announces-initial-commercialization-of-cannabinoids-based-personalized-diagnostics-for-cancer-patients-300403359.html
A Hard Look at Cannabics Pharmaceuticals Inc $CNBX
http://oracledispatch.com/2017/03/13/hard-look-cannabics-pharmaceuticals-inc-otcmktscnbx/
Recent CNBX News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:27:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/12/2024 03:13:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/14/2023 02:28:11 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM